2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92546°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
»ç¹Ù½º-ÆÈ¸®ÄÚ, ¾÷¹«Çù¾à ü°á¡¦ ±Û·Î¹ú ÅõÀÚ À¯µ¿¼º Çõ½Å (2025-01-24)
MFM ÀÎÁõ ¸Æ¼¼ÀÌÇÁ 3In1 °í¼Ó ¹«¼±ÃæÀü±â (2023-11-18)
Bruce ATS¢â Announces Regulatory Approval, Now Open for Busi... (2025-03-27)
±¸±Û Ŭ¶ó¿ìµå, Ŭ·è°ú ÆÄÆ®³Ê½Ê °­È­ (2024-11-03)
³× ¹øÂ° ·ÎÄýº¸¶ÀϿ¸¶ÄÏ °³ÃÖ (2024-10-24)
º£Æ®³² ´ëÇеé°ú ¹Ì·¡ÀÎÀç À°¼º ÀåÇÐ ÃßÁø (2024-12-25)
VeriSilicon Launches ISP9000: The Next-Generation AI-Embedde... (2025-04-17)
µ¿¾ÆÁ¦¾à, ½áÅ¥¶õ ¾Æ¸£±â´Ñ 6000 CUÆíÀÇÁ¡ ´Üµ¶ Ãâ½Ã (2025-01-25)
LTO ¹èÅ͸®, öµµ Á¦¾îÀü¿ø ½ÃÀåÀÇ °ÔÀÓ Ã¼ÀÎÀú (2025-01-25)
¡®»çÀåÀº ¾Æ¹«³ª Çϳª¡¯ ¼ÕÀÍ –170%´Â ³ªµµ óÀ½ ºÁ¡¦ (2025-01-25)
LG Empowers Vietnam¡¯s Youth With Dynamic Learning Experienc... (2024-12-15)
150¸¸ »çȸº¹Áö»ç ½Ã´ë ¡®»çȸº¹Áö»ç ÀڰݽŰíÁ¦¡¯ (2024-12-15)
À̺êÀÚ¸®, »ç¶ûÀÇ ÀÌºÒ 1300ä ±âºÎ¡¦ ´©Àû 36¾ï¿ø »ó´ç (2024-12-15)
Tourism in Asia and the Pacific Reach 85% of 2019 Levels, Wi... (2024-12-15)
¼ÒºñÇൿ ±â¹ÝÀÇ »õ·Î¿î ½Å¿ëÆò°¡ ½Ã½ºÅÛ ±¸Ãà (2024-11-04)
Savvy Sipping, Culinary Craftmanship, and Pop Culture Crazes... (2024-12-05)
ÀâÄÚ¸®¾Æ Ŭ¸¯, ·ÐĪ 3°³¿ù ¸¸¿¡ °ø°í ¼ö 600% Áõ°¡ (2024-11-05)
À̺êÀÚ¸®, üÇèÇü ¸ÅÀå¿¡¼­ ±Í¶Ñ¶ó¹Ì ¼÷¸é ¸ÅÆ® üÇèÁ¸ ¿î¿µ (2024-12-16)
¸Ó½Å·¯´× ÀÌ¿ëÇÑ À¯±â¿­Àü¼ÒÀÚ ¼º´É ÃÖÀûÈ­ ±â¼ú °³¹ß (2024-12-16)
»ï¼º¹ÙÀÌ¿À·ÎÁ÷½º, º¹ÁöºÎ ¡®2024 °Ç°­Ä£È­ ¿ì¼ö ±â¾÷¡¯ ¼±Á¤ (2024-12-16)
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evalu... (2025-06-18)
»ïô½Ã ³óÃÌÅ©¸®¿¡ÀÌÅõ¾î ¡®»ïô Èú¸µ »ó»óÅõ¾î - ô! Çϸé ô!... (2024-09-26)
CompareForexBrokers Announces 2025 Annual Award Winners (2024-12-27)
Çѱ¹±³Á÷¿ø°øÁ¦È¸, ¼­¿ï½Ã »çȸº¹Áö½Ã¼³ ¼öÀǰè¾à Àü¹®¼º ³ô¿© (2024-10-27)
Çѱ¹³²µ¿¹ßÀü ºÐ´ç¹ßÀüº»ºÎ, Áö¿ª Àå¾ÖÀÎ ¾ÈÀü ¹°Ç° Àü´Þ (2024-10-07)
       [ÀÌÀü][1]....[378][379][380][381][382][383][384][385][386]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..